ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.15M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−501.00
Price / share
$536.26
Trade value
$268.67K
% of position
Common Stock
Shares
−905.00
Price / share
$537.43
Trade value
$486.37K
% of position
Common Stock
Shares
−655.00
Price / share
$538.62
Trade value
$352.80K
% of position
Common Stock
Shares
−931.00
Price / share
$539.50
Trade value
$502.28K
% of position
Common Stock
Shares
−1.03K
Price / share
$540.50
Trade value
$555.63K
% of position
Common Stock
Shares
−1.24K
Price / share
$541.66
Trade value
$671.12K
% of position
Common Stock
Shares
−918.00
Price / share
$542.56
Trade value
$498.07K
% of position
Common Stock
Shares
−783.00
Price / share
$543.54
Trade value
$425.59K
% of position
Common Stock
Shares
−1.26K
Price / share
$544.59
Trade value
$686.19K
% of position
Common Stock
Shares
−920.00
Price / share
$545.69
Trade value
$502.04K
% of position
Common Stock
Shares
−360.00
Price / share
$546.63
Trade value
$196.79K
% of position
Net shares
+0.00
Net value
-$4.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/5/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −501.00 | $536.26 | $268.67K | 0.2% | 333.94K | 333.44K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −905.00 | $537.43 | $486.37K | 0.3% | 333.44K | 332.54K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −655.00 | $538.62 | $352.80K | 0.2% | 332.54K | 331.88K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −931.00 | $539.50 | $502.28K | 0.3% | 331.88K | 330.95K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −1.03K | $540.50 | $555.63K | 0.3% | 330.95K | 329.92K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −1.24K | $541.66 | $671.12K | 0.4% | 329.92K | 328.68K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −918.00 | $542.56 | $498.07K | 0.3% | 328.68K | 327.77K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −783.00 | $543.54 | $425.59K | 0.2% | 327.77K | 326.98K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −1.26K | $544.59 | $686.19K | 0.4% | 326.98K | 325.72K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −920.00 | $545.69 | $502.04K | 0.3% | 325.72K | 324.80K |
| Common Stock Indirect | 10/5/2026 | S · Sale | −360.00 | $546.63 | $196.79K | 0.1% | 324.80K | 324.44K |
| Total | +0.00 | -$4.03M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
299.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/5/2026 | M · Option Exercise | −9.50K | 117.76 | — | 299.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 166.00 | Indirect |
| Common Stock | 45.60K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |